Kurse + Charts + Realtime | News + Analysen | Fundamental | Unternehmen | zugeh. Wertpapiere | Aktion | |
---|---|---|---|---|---|---|
Kurs + Chart | Chart (gross) | News + Adhoc | Bilanz/GuV | Termine | Strukturierte Produkte | Portfolio |
Times + Sales | Chartvergleich | Analysen | Schätzungen | Profil | Watchlist | |
Börsenplätze | Realtime Push | Kursziele | Dividende/GV | |||
Orderbuch | Analysen | |||||
Historisch | Ausblick |
Kurse + Charts + Realtime
News + Analysen
Fundamental
zugeh. Wertpapiere
Aktionärsstruktur
Inhaber | in % |
---|---|
Freefloat | 99.86 |
Vanguard Group, Inc. (Subfiler) | 8.67 |
The Vanguard Group, Inc. | 8.29 |
State Street Corp. | 4.42 |
Vanguard Total Stock Market ETF | 3.13 |
BlackRock Fund Advisors | 2.97 |
Vanguard 500 Index Fund | 2.41 |
Capital Research & Management Co. (International Investors) | 2.40 |
BlackRock Institutional Trust Co. NA | 2.22 |
JPMorgan Investment Management, Inc. | 2.20 |
Geode Capital Management LLC | 2.05 |
Capital Research & Management Co. (Global Investors) | 1.81 |
Charles Schwab Investment Management, Inc. | 1.29 |
Fidelity 500 Index Fund | 1.15 |
Norges Bank (13F) | 1.06 |
*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.
Personal
2018 | 2019 | 2020 | 2021 | 2022 | |
---|---|---|---|---|---|
Personal am Ende des Jahres | 30'000 | 30'000 | 47'000 | 50'000 | 50'000 |
Umsatz pro Mitarbeiter in Mio. EUR | 1.09 | 1.11 | 0.97 | 1.12 | 1.16 |
Bilanz (in Mio. EUR) - Aktiva
2018 | 2019 | 2020 | 2021 | 2022 | |
---|---|---|---|---|---|
Summe Umlaufvermögen | 16'945 | 49'519 | 24'173 | 27'928 | 28'463 |
Summe Anlagevermögen | 31'864 | 58'916 | 100'139 | 92'983 | 81'445 |
Summe Aktiva | 59'352 | 89'115 | 150'565 | 146'529 | 138'805 |
Bilanz (in Mio. EUR) - Passiva
2018 | 2019 | 2020 | 2021 | 2022 | |
---|---|---|---|---|---|
Gesamtverschuldung/ -verbindlichkeiten | 40'310 | 67'088 | 87'063 | 77'575 | 64'191 |
Summe Fremdkapital | 67'798 | 97'287 | 137'468 | 131'093 | 121'518 |
Summe Eigenkapital | -8'446 | -8'172 | 13'097 | 15'436 | 17'287 |
Summe Passiva | 59'352 | 89'115 | 150'565 | 146'529 | 138'805 |
Adresse
1 North Waukegan Road, 60064-6400 North Chicago | |
Telefon | +1 (847) 932-7900 |
URL | http://www.abbvie.com |
Management
Azita Saleki-Gerhardt
Executive Vice President-Operations |
Brett J. Hart
Independent Director |
Brian L. Durkin
Vice President |
Carrie Strom
Senior VP & President-Global Allergan Aesthetics |
Chris Boone
Vice President & Global Head-Health Economics |
Edward J. Rapp
Independent Director |
Esteban Plata
Vice President-Western Europe & Canada |
Frederick H. Waddell
Independent Director |
Glenn Fletcher Tilton
Lead Independent Director |
Jeffrey Ryan Stewart
Chief Commercial Officer & Executive VP |
Jennifer L. Davis
Independent Director |
Katherine Rielly-Gauvin
Vice President-Global Commercial Development |
Kevin K. Buckbee
Senior Vice President & Controller |
Liz Shea
Head-Investor Relations |
Melody B. Meyer
Independent Non-Executive Director |
Perry C. Siatis
Secretary, Executive VP & General Counsel |
Rebecca Brown Roberts
Independent Director |
Richard A. Gonzalez
Chairman & Chief Executive Officer |
Robert A. Michael
Vice Chairman, President & Chief Operating Officer |
Robert J. Alpern
Independent Director |
Roxanne Schuh Austin
Independent Director |
Scott T. Reents
Chief Financial Officer & Executive Vice President |
Susan E. Quaggin
Independent Director |
Thomas C. Freyman
Independent Director |
Thomas J. Hudson
Chief Scientific Officer, Senior VP-R&D |
Timothy J. Richmond
Chief Human Resources Officer & Executive VP |
Todd D. Bosse
Vice President-Investor Relations |
William H. L. Burnside
Independent Director |